Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard

被引：2
|
作者：
Yalman, Deniz [1 ]
Selek, Ugur [2 ,3 ]
机构：
[1] Ege Univ, Sch Med, Dept Radiat Oncol, 35100 Bornova, Izmir, Turkey
[2] Koc Univ, Sch Med, Dept Radiat Oncol, Istanbul, Turkey
[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77004 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2015年 / 3卷 / 11期
关键词：
D O I：
10.3978/j.issn.2305-5839.2015.06.23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
    Pascoe, A. C.
    Foweraker, K.
    Esler, C.
    Morgan, S.
    Wallace, A.
    Launders, D.
    Harron, E.
    CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
  • [22] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [23] Phase II Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) in Surgically Operable Stage I Non-Small Cell Lung Cancer (STARS)
    Chang, Joe Y.
    Mehran, Reza
    Balter, Peter
    Mcrae, Stephen
    Feng, Lei
    Berry, Donald
    Komaki, Ritsuko U.
    Roth, Jack
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S563 - S563
  • [24] Is stereotactic ablative radiotherapy (SABR) a safe treatment for multiple primary lung cancer (MPLC) non-small cell lung cancer (NSCLC)?
    Murray, P. F.
    Spencer, K.
    Snee, M.
    Dickinson, P.
    Jain, P.
    Clarke, K.
    Franks, K.
    LUNG CANCER, 2016, 91 : S48 - S48
  • [25] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Inderdeep Dhaliwal
    Shayan Kassirian
    Michael A. Mitchell
    Mehdi Qiabi
    Andrew Warner
    Alexander V. Louie
    Harvey H. Wong
    Christine M. McDonald
    Jason Rajchgot
    David A. Palma
    BMC Cancer, 22
  • [26] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Dhaliwal, Inderdeep
    Kassirian, Shayan
    Mitchell, Michael A.
    Qiabi, Mehdi
    Warner, Andrew
    Louie, Alexander, V
    Wong, Harvey H.
    McDonald, Christine M.
    Rajchgot, Jason
    Palma, David A.
    BMC CANCER, 2022, 22 (01)
  • [27] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
    Beal, J.
    Gomes, D.
    Taranto, P.
    Koch, L.
    Rezende, A. C.
    Samano, M.
    Bibas, B.
    Gomes, O.
    Campregher, P.
    Severino, P.
    Marti, L.
    Paes, V.
    Chate, R.
    Sales, D.
    Schvartsman, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652
  • [28] Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study
    Schvartsman, G.
    Amarato, Y.
    dos Santos, G. Prado
    Gomes, D. Bugano Diniz
    Koch, L. D. O.
    Bibas, B.
    Gomes, O., Jr.
    Campregher, P. Vidal
    Severino, P.
    Marti, L. Cavalheiro
    Ribeiro, V. Paes
    Leaden, L.
    Chate, R. Caruso
    de Campos, J. Ribas Milanez
    Sousa, V. A. Ramos
    Taranto, P.
    Moura, F. S.
    Terra, R. M.
    Rezende, A. C. P. D.
    Samano, M. Naoyuki
    ANNALS OF ONCOLOGY, 2024, 35 : S785 - S785
  • [29] Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Sanuki, Naoko
    Tsurugai, Yuichiro
    Aoki, Yousuke
    Oku, Yohei
    Hara, Yu
    Akiba, Takeshi
    Shigematsu, Naoyuki
    LUNG CANCER, 2017, 109 : 62 - 67
  • [30] Clinical implementation of stereotactic ablative radiotherapy (SABR) for lung early stage NSCLC
    Routsis, D.
    Dean, J.
    Archer, S.
    Ferriera, C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S304 - S304
12345